Split History
How to Retire on Monthly Dividends »    GENE Historical Stock Prices »

Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Genetic Technologies is a molecular diagnostics company that provides predictive testing and assessment tools to help physicians manage women's health. Co.'s key product, BREVAGenplus, was a clinically validated risk assessment test for non-hereditary breast cancer. Co. has launched the first generation BREVAGen test across the U.S. via its U.S. subsidiary Phenogen Sciences Inc. Co. has developed two new cancer risk assessment tests branded as GeneType for Colorectal Cancer and GeneType for Breast Cancer. Co. also develops other risk assessment tests across a range of diseases, including cardiovascular disease, type 2 diabetes, prostate cancer and melanoma. According to our GENE split history records, Genetic Technologies has had 3 splits.
GENE split history picture
Genetic Technologies (GENE) has 3 splits in our GENE split history database. The first split for GENE took place on January 20, 2015. This was a 1 for 5 reverse split, meaning for each 5 shares of GENE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split. GENE's second split took place on August 15, 2019. This was a 1 for 4 reverse split, meaning for each 4 shares of GENE owned pre-split, the shareholder now owned 1 share. For example, a 200 share position pre-split, became a 50 share position following the split. GENE's third split took place on December 14, 2023. This was a 1 for 5 reverse split, meaning for each 5 shares of GENE owned pre-split, the shareholder now owned 1 share. For example, a 50 share position pre-split, became a 10 share position following the split.

When a company such as Genetic Technologies conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the GENE split history from start to finish, an original position size of 1000 shares would have turned into 10 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Genetic Technologies shares, starting with a $10,000 purchase of GENE, presented on a split-history-adjusted basis factoring in the complete GENE split history. GENE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/24/2014
End date: 07/22/2024
Start price/share: $92.00
End price/share: $0.78
Dividends collected/share: $0.00
Total return: -99.15%
Average Annual Total Return: -37.93%
Starting investment: $10,000.00
Ending investment: $84.77
Years: 10.00
Date Ratio
01/20/20151 for 5
08/15/20191 for 4
12/14/20231 for 5
GENE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

GERN Split History
GILD Split History
GNCA Split History
GNVC Split History
GRFS Split History
GSK Split History
GTS Split History
GTXI Split History
HAE Split History
HBIO Split History

Email EnvelopeFree GENE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Nauticus Robotics, Inc. (KITT)
Benson Hill, Inc. (BHIL)
Scorpius Holdings, Inc (SCPX)
Senti Biosciences, Inc. (SNTI)
Catheter Precision, Inc. (VTAK)
SITE Centers Corp. (SITC)
MGO Global Inc. (MGOL)
Deckers Brands (DECK)
Alzamend Neuro, Inc. (ALZN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

GENE Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.